Welcome! This is the NEW free version of the SciBITES Pharma News Engine from SciBite. By using this site you to accept our Terms & Conditions which the use of cookies to enhance your user experience.

Trisomy for synaptojanin1 in Down syndrome is functionally linked to the enlargement of early endosomes.

Recieved:15-Jul-2012 00:00:00

Centre de Recherche de l’Institut du Cerveau et de la Moelle, CNRS UMR7225, UPMC, INSERM UMRS975, Hôpital Pitié-Salpêtri...
Cossec, JC; Lavaur, J; Berman, DE; Rivals, I; Hoischen, A; Stora, S; Ripoll, C; Mircher, C; Grattau, Y; Olivomarin, JC; de Chaumont, F; Lecourtois, M; Antonarakis, SE; Veltman, JA; Delabar, JM; Duyckaerts, C; Di Paolo, G; Potier, MC


Enlarged early endosomes have been observed in neurons and fibroblasts in Down syndrome (DS). These endosome abnormalities have been implicated in the early development of Alzheimer's disease (AD) pathology in these subjects. Here, we show the presence of enlarged endosomes in blood mononuclear cells and lymphoblastoid cell lines (LCLs) from individuals with DS using immunofluorescence and confocal microscopy. Genotype-phenotype correlations in LCLs carrying partial trisomies 21 revealed that triplication of a 2.56 Mb locus in 21q22.11 is associated with the endosomal abnormalities. This locus contains the gene encoding the phosphoinositide phosphatase synaptojanin 1 (SYNJ1), a key regulator of the signalling phospholipid phosphatidylinositol-4,5-biphosphate that has been shown to regulate clathrin-mediated endocytosis. We found that SYNJ1 transcripts are increased in LCLs from individuals with DS and that overexpression of SYNJ1 in a neuroblastoma cell line as well as in transgenic mice leads to enlarged endosomes. Moreover, the proportion of enlarged endosomes in fibroblasts from an individual with DS was reduced after silencing SYNJ1 expression with RNA interference. In LCLs carrying amyloid precursor protein (APP) microduplications causing autosomal dominant early-onset AD, enlarged endosomes were absent, suggesting that APP overexpression alone is not involved in the modification of early endosomes in this cell type. These findings provide new insights into the contribution of SYNJ1 overexpression to the endosomal changes observed in DS and suggest an attractive new target for rescuing endocytic dysfunction and lipid metabolism in DS and in AD.

Major Topics:
synaptojanin 1   
overexpressing    Lipid Metabolism    pathology    RNA Interference    phospholipids    Phenotype    immunostaining    Endocytosis    Genotype    mononuclear    Trisomy   
clathrin    amyloid    synaptojanin   
neuroblastoma   
GenomeVariation   
Alzheimer Disease    Down Syndrome    Neuroblastoma   

Taxonomies
Click on any component of the trees below to see articles for any topic that is a member of that branch.